Financial Trends -- 6.5/10
Autoliv shows solid but unspectacular financial trends. Revenue recovered from a flat 2024
(-0.8%) with accelerating quarterly momentum through 2025 (+7.7% in Q4). Margins expanded
+60bps at the full-year level with a credible path to the 12% adj operating margin target,
but Q4 YoY margin decline (-140bps) and quality-of-earnings concerns (one-time items, loss
of out-of-period compensation) temper enthusiasm. EPS growth of +18.4% is strong,
structurally supported by aggressive buybacks (-4.4% share count). FCF is the standout,
up 48% YoY to $734M with declining CapEx intensity. The story is one of steady, self-help-driven
margin improvement in a cyclically challenging end-market -- solid execution, but not a
high-growth compounder.
Weight: 25%
FY2025 Adj Operating Margin
10.3%
vs 9.7% in FY24 | +60bps YoY | Path to 12% target
FY2025 Adj EPS
$9.85
+18.4% YoY | Buybacks added ~4.4pp | 3x in 5 years
FY2025 Free Cash Flow
$734M
+48% YoY | CapEx 4.5% of sales vs 5.4% PY | Accelerating
FY2025 EBITDA (Co Policy)
$1,521M
+9.1% YoY | Slight accel from +7.5% in FY24
Annual Financial Summary (USD M, FYE December 31)
| Metric | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Total Net Sales | 7,447M | 8,230M | 8,842M | 10,475M | 10,390M | 10,815M |
| Rev YoY | — | +10.5% | +7.4% | +18.5% | -0.8% | +4.1% |
| Airbag Products | 4,824M | 5,380M | 5,807M | 7,055M | 7,023M | 7,302M |
| Seatbelt Products | 2,623M | 2,850M | 3,035M | 3,420M | 3,367M | 3,513M |
| Gross Profit | 1,247M | 1,511M | 1,396M | 1,822M | 1,927M | 2,074M |
| Gross Margin | 16.7% | 18.4% | 15.8% | 17.4% | 18.5% | 19.2% |
| Net Income | 188M | 437M | 425M | 489M | 648M | 736M |
| Adj Operating Income | — | — | — | — | 1,007M | 1,114M |
| Adj Op Margin | — | — | — | — | 9.7% | 10.3% |
| Adj Diluted EPS | — | — | — | — | $8.32 | $9.85 |
| EPS YoY | — | — | — | — | — | +18.4% |
| EBITDA (Co Policy) | 830M | 1,077M | 961M | 1,297M | 1,394M | 1,521M |
| EBITDA YoY | — | +29.8% | -10.8% | +35.0% | +7.5% | +9.1% |
| Operating Cash Flow | 849M | 754M | 713M | 982M | 1,059M | 1,157M |
| CapEx Net | (340M) | (454M) | (485M) | (569M) | (563M) | (423M) |
| Free Cash Flow | 509M | 300M | 228M | 414M | 497M | 734M |
| FCF YoY | — | -41% | -24% | +82% | +20% | +48% |
Note: Autoliv reports under US GAAP in USD. Fiscal year ends December 31. All
figures in millions of USD except per-share data. Adjusted metrics exclude capacity
alignments, antitrust-related items, and related tax effects. EBITDA per company
policy methodology.
Revenue recovered to $10.8B in 2025, finally surpassing the 2023 peak.
Total net sales grew from
$7,447M in FY2020 to
$10,815M in FY2025. The 2023 surge
(+18.5%) was largely supply-chain recovery and inflation pass-throughs, followed by a
flat 2024 (-0.8%) driven by negative FX, lower LVP, and unfavorable China mix. FY2025
organic growth of ~3% was driven by India, Chinese OEM gains, and tariff compensations.
Gross margin expanded to
19.2%, a new high.
Regional Revenue Breakdown (USD M)
| Metric | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Europe | 2,067M | 2,289M | 2,355M | 2,877M | 2,946M | 3,116M |
| Americas | 2,337M | 2,535M | 2,967M | 3,526M | 3,424M | 3,480M |
| China | 1,541M | 1,766M | 1,883M | 2,105M | 2,010M | 2,095M |
| Asia ex-China | — | — | — | 1,968M | 2,010M | 2,124M |
Asia ex-China is the brightest regional spot; Americas has stalled.
Americas declined -2.9% in 2024 and barely recovered +1.6% in 2025. Europe grew steadily
(+5.8% YoY in 2025). China declined -4.5% in 2024, recovered +4.2% in 2025 but remains
below 2023 levels. Asia ex-China grew +5.7% in 2025, driven by India (now ~5% of sales,
60% market share, CPV rising from $120 to $140 and headed to $160-170).
Share Count Reduction and Capital Return
Aggressive buyback program is a meaningful structural EPS tailwind.
Weighted avg diluted shares declined from
80.4M in FY2024 to
76.9M in FY2025 (-4.4%). Shares
reduced over 12% since the buyback program started in 2022. Annual target of $300-500M
in repurchases. Management highlights they have "more than tripled" EPS over the past
five years, driven by profit growth and buybacks.
Quarterly Revenue, Margins, and EPS (Q1 2023 through Q4 2025)
| Metric | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,493M | 2,635M | 2,596M | 2,751M | 2,615M | 2,605M | 2,555M | 2,616M | 2,578M | 2,714M | 2,706M | 2,817M |
| Rev YoY | — | — | — | — | +4.9% | -1.1% | -1.6% | -4.9% | -1.4% | +4.2% | +5.9% | +7.7% |
| Adj Op Margin | 5.3% | 8.1% | 9.3% | 12.1% | 7.6% | 8.5% | 9.3% | 13.4% | 9.9% | 9.3% | 10.0% | 12.0% |
| Margin YoY (bps) | — | — | — | — | +230 | +40 | 0 | +130 | +230 | +80 | +70 | -140 |
| Adj Diluted EPS | $0.89 | $1.92 | $1.66 | $3.74 | $1.57 | $1.88 | $1.84 | $3.05 | $2.15 | $2.21 | $2.32 | $3.19 |
| EPS YoY | — | — | — | — | +76% | -2.1% | +10.8% | -18.4% | +36.9% | +17.6% | +26.1% | +4.6% |
Revenue clearly accelerating; margins and EPS decelerating on tough comps.
Revenue YoY improved sequentially through 2025: -1.4% to +4.2% to +5.9% to +7.7%.
However, adj operating margin YoY expansion faded from +230bps in Q1 to -140bps in Q4,
as Q4 2024 benefited from ~$45M of out-of-period inflation compensation that did not recur.
Q3 2025 included a one-time $15M supplier compensation that inflated the result. Adj EPS
growth decelerated from +36.9% in Q1 to +4.6% in Q4 due to the tough Q4 2024 comp
(record quarter of
$3.05).
Quarterly Free Cash Flow and EBITDA (Q1 2024 through Q4 2025)
FCF strongly accelerating -- the standout metric in the ALV story.
Full-year FCF improved from
$497M in FY2024 to
$734M in FY2025, up +48% YoY.
Drivers: higher net income, lower CapEx intensity (4.5% of sales, down from 5.4%), and
improving working capital. Cash conversion of ~87% in Q3 2025 (LTM), meeting the 80%
target. Q4 2025 FCF of
$434M was the strongest quarter,
up $146M vs Q4 2024.
Acceleration / Deceleration Analysis
| Signal | Detail | Direction |
|---|---|---|
| Revenue Growth (Quarterly YoY) | -1.4% (Q1) to +4.2% (Q2) to +5.9% (Q3) to +7.7% (Q4) -- clearly accelerating | Accelerating |
| Adj Op Margin (YoY Change) | +230bps (Q1) to +80bps (Q2) to +70bps (Q3) to -140bps (Q4) -- fading, turned negative | Decelerating |
| Adj EPS Growth (Quarterly YoY) | +36.9% (Q1) to +17.6% (Q2) to +26.1% (Q3) to +4.6% (Q4) -- decelerating on tough comp | Decelerating |
| Free Cash Flow (Q vs PY Q) | +$2M (Q1) to -$31M (Q2) to +$121M (Q3) to +$146M (Q4) -- strongly accelerating | Accelerating |
| EBITDA Growth (Annual) | +7.5% (FY24) to +9.1% (FY25) -- slight acceleration from $1,394M to $1,521M | Accelerating |
| Organic Outperformance vs LVP | ~1.5pp in 2025, below 2-3pp guided range and below 2024 (~2pp) -- disappointing | Below Target |
| Share Count Reduction | -4.4% YoY diluted shares (80.4M to 76.9M) -- structural EPS support | Positive |
Penalty / Modifier Assessment
| Factor | Impact | Detail |
|---|---|---|
| Q4 2025 margin YoY decline (-140bps) | -0.50 | Deceleration signal -- margin expansion turned negative in Q4 due to loss of out-of-period comp. |
| Organic outperformance below guided range | -0.25 | ~1.5pp vs 2-3pp target; China regional mix and delayed launches. |
| Revenue still near 2023 peak until 2025 | -0.25 | $10,815M in 2025 only 3.2% above $10,475M in 2023 -- effectively flat for two years. |
| One-time items inflating results (supplier comp Q3 2025) | -0.25 | $15M supplier compensation in Q3 2025 inflated margin; quality of earnings concern. |
| FCF strongly accelerating (+48% YoY) | +0.25 | $734M FCF driven by lower CapEx intensity and higher profitability. |
| Share count reduction (4.4% YoY) | +0.25 | Structural EPS support from aggressive $300-500M annual buyback program. |
| Clear path to 12% adj operating margin target | +0.25 | Q4 2025 achieved 12.0%; framework tracking well on indirect headcount and automation. |
Final Score: 6.5 / 10. ALV shows solid but unspectacular
financial trends. Revenue has recovered from a flat 2024 with accelerating quarterly momentum.
Margins expanded +60bps at the full-year level with a credible path to the 12% target, but Q4
YoY margin decline and quality-of-earnings concerns (one-time items, loss of out-of-period comp)
temper enthusiasm. EPS growth of +18.4% is strong, structurally supported by buybacks. FCF is the
standout, up 48% with declining CapEx intensity. The main drags are: organic outperformance below
management target, regional mix headwinds from China (though improving), and a revenue base that
only just surpassed 2023 levels. Steady, self-help-driven margin improvement in a cyclically
challenging end-market -- solid execution, but not a high-growth compounder.
Transcript Context (Q3 2024 - Q4 2025 Earnings Calls)
Margin Improvement Framework: Management confident in reaching 12% adj operating
margin target (medium-term). Components: +80bps from indirect headcount reduction, +60bps from
call-off normalization, +90bps from growth/automation. All tracking well except growth component
slightly behind. Direct headcount reduced 1,900 YoY in Q3 2025 despite +4% organic growth.
Call-off accuracy at 94% in Q3 2025, improving YoY.
Content Per Vehicle / Growth Drivers: India CPV: $120 (2024) to $140 (2025) to
$160-170 (2026-27). India = 5% of sales with 60% market share. China CPV dipped in 2024 due to
mix, expected to recover 2025+. Front center airbags driving higher CPV across multiple new model
launches. New JV with HSAE for safety electronics, partnership with CATARC for China safety standards.
Auto Production Outlook Risks: Tariff uncertainty: ~$200M gross exposure, expect
to pass through to customers with ~20bps dilutive margin impact (75-80% recovered in-quarter).
Europe demand weak; US tariff-related uncertainty on affordability. China subsidy programs
supporting near-term but uncertain extension into 2026. Engineering income temporarily depressed
in H2 2025, expected to normalize in 2026.
CapEx Discipline: Lower CapEx expected to persist (~4.5% of sales vs historical 5%+).
Management guiding for continued FCF improvement in 2026, with cash conversion meeting 80% target.
Lower CapEx intensity reflects shift toward automation and efficiency rather than greenfield expansion.
Daloopa (company_id: 11) and Autoliv earnings call transcripts (Q3 2024 - Q4 2025)